Pfizer Inc. (PFE) — closed signal from August 29, 2025
Target reached Published before the outcome was known, scored automatically when the window closed on November 27, 2025.
Predicted vs. what happened
What happened
Hit or exceeded the predicted growth inside the window.
The thesis — published August 29, 2025
Pfizer looks beaten down, but buyers seem to be returning. Trading activity has been heavy, which often signals that most sellers are done, while overall mood on the stock is still steady. Over the next 0-3 months, the aim is a bounce back toward its recent average price. A yield-focused review on Aug 29 scored it 60%, which supports the idea of steady total returns. Plan to buy in steps and use an exit below recent lows to manage risk.
Primary drivers
- Price looks very oversold, and trading has been much heavier than usual
- Income and buyback mix looks supportive in an independent screen
- Investors may favor safer healthcare names in choppy markets
- Price is stabilizing near recent lows, hinting at a forming floor
How it played out
PFE: peak gain stopped at 11.8%
Lyra published PFE at 24.35 on 2025-08-29 with a short-term bounce thesis. The expected growth was 12%. The thesis pointed to an oversold price, heavier trading, a supportive income and buyback screen, possible demand for safer healthcare names, and signs of stabilization near recent lows.
Inside the window, PFE peaked at 27.21 on 2025-10-03, with a peak gain of 11.8%. The listed target was 26.8, but the supplied outcome says the target was never reached. The stock ended at 25.71 on 2025-11-27. The thesis mostly played out, but it missed the full growth call.
What happened during the window
On 2025-09-22, Pfizer agreed to buy Metsera, a development-stage weight-loss drug company, in a deal with an initial cash offer of 47.50 per share and possible additional payments of 22.50 per share. On 2025-10-31, Pfizer filed a lawsuit seeking to block Novo Nordisk's competing bid for Metsera.
Prices are shown split- and dividend-adjusted, matching what public charts show today.
Share this receipt
A scored call, published before the outcome was known. Paste the link anywhere — it unfurls as the card above.
Read the next call before it closes.
This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.